Compare ALSN & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALSN | DVA |
|---|---|---|
| Founded | 1915 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.2B |
| IPO Year | 2012 | 1995 |
| Metric | ALSN | DVA |
|---|---|---|
| Price | $109.51 | $108.01 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 4 |
| Target Price | $100.57 | ★ $145.00 |
| AVG Volume (30 Days) | 747.0K | ★ 796.3K |
| Earning Date | 02-10-2026 | 02-02-2026 |
| Dividend Yield | ★ 0.97% | N/A |
| EPS Growth | N/A | ★ 5.63 |
| EPS | 8.15 | ★ 9.76 |
| Revenue | $3,069,000,000.00 | ★ $13,317,965,000.00 |
| Revenue This Year | N/A | $6.50 |
| Revenue Next Year | $0.23 | $2.97 |
| P/E Ratio | $13.63 | ★ $11.18 |
| Revenue Growth | N/A | ★ 5.14 |
| 52 Week Low | $76.01 | $101.00 |
| 52 Week High | $121.81 | $179.60 |
| Indicator | ALSN | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 68.06 | 42.21 |
| Support Level | $108.37 | $103.48 |
| Resistance Level | $113.31 | $110.43 |
| Average True Range (ATR) | 2.88 | 3.29 |
| MACD | 0.29 | 0.06 |
| Stochastic Oscillator | 76.96 | 47.40 |
Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.